Lv11
10 积分 2021-02-13 加入
PBPK model of pegylated liposomal doxorubicin to simultaneously predict the concentration–time profile of encapsulated and free doxorubicin in tissues
1小时前
待确认
Demonstration of discriminatory power and prediction of in vivo behaviour of complex liposomal injectable formulation using physiologically based pharmacokinetic modeling
8天前
已完结
Population pharmacokinetics and pharmacodynamics of L-asparaginase and its impact on the development of pancreatitis and hypersensitivity reactions in children with leukemia under treatment
16天前
已完结
A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum
25天前
已完结
Development of a novel anti-PEG antibody assay enabling investigation of potential immunogenicity triggered by the PEG moiety of biotherapeutics
25天前
已完结
Statistical Tutorial for Cut‐Point Determination in Immunogenicity Studies
29天前
已完结
Mechanistic PBPK/PD modeling of free and nano-liposomal irinotecan reveals formulation-specific determinants of disposition and efficacy
1个月前
已完结
Mechanistic PBPK/PD modeling of free and nano-liposomal irinotecan reveals formulation-specific determinants of disposition and efficacy
1个月前
已完结
The curious case of anti-PEG antibodies
1个月前
已完结
Functionalization Strategies for the Delivery of Anticancer Agents: Advancing Tumor-Targeted Liposomal Systems for Cancer Therapy
1个月前
已完结
皖公网安备34019202002308
